About Atlantic Therapeutics
Atlantic Therapeutics is a company based in Oranmore (Ireland) founded in 2013 was acquired by Caldera Medical in September 2023. Atlantic Therapeutics has raised $70.62 million across 8 funding rounds from investors including SVB, Enterprise Ireland and Andera Partners. Atlantic Therapeutics offers products and services including New Collections. Atlantic Therapeutics operates in a competitive market with competitors including Axonics, Laborie Medical, Amber Therapeutics, ONWARD and NeuSpera Medical, among others.
- Headquarter Oranmore, Ireland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Atlantic Therapeutics Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$70.62 M (USD)
in 8 rounds
-
Latest Funding Round
$20.41 M (USD), Series B
Jan 20, 2022
-
Investors
SVB
& 9 more
-
Employee Count
Not available
-
Acquired by
Caldera Medical
(Sep 06, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atlantic Therapeutics
Atlantic Therapeutics offers a comprehensive portfolio of products and services, including New Collections.
Exclusive items for online purchase and updates
People of Atlantic Therapeutics
Unlock access to complete
Funding Insights of Atlantic Therapeutics
Atlantic Therapeutics has successfully raised a total of $70.62M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $20.41 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Atlantic Therapeutics
Atlantic Therapeutics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Enterprise Ireland and Andera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity & debt fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Private equity investments in life sciences businesses are managed.
|
Locked | Locked | Locked | |
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Locked | Locked | Locked |
Investor details for Atlantic Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Atlantic Therapeutics
Investment portfolio details for Atlantic Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Atlantic Therapeutics
Detailed financials for Atlantic Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atlantic Therapeutics Comparisons
Peer comparison for Atlantic Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Atlantic Therapeutics
Atlantic Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Laborie Medical, Amber Therapeutics, ONWARD and NeuSpera Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| Locked | Locked | Locked |
Medical products for female lower urinary tract dysfunctions are provided.
|
|
| Locked | Locked | Locked |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| Locked | Locked | Locked |
Therapeutic devices for spinal cord injuries are developed and delivered.
|
|
| Locked | Locked | Locked |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| Locked | Locked | Locked |
Developer of a neurostimulation system for managing intractable chronic pain
|
Detailed competitors of Atlantic Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atlantic Therapeutics
Complete news archive for Atlantic Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atlantic Therapeutics
Atlantic Therapeutics was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Atlantic Therapeutics is headquartered in Oranmore, Ireland. It is registered at Oranmore, County Galway, Ireland.
Susan Trent is the current CEO of Atlantic Therapeutics.
Atlantic Therapeutics is a funded company, having raised a total of $70.62M across 8 funding rounds to date.
Atlantic Therapeutics was founded in 2013 in Oranmore, Ireland, within the medical device sector. Non-invasive wearable devices, resembling cycling shorts, are developed to deliver electrical muscle stimulation for pelvic floor contractions. These devices are controlled via a handheld unit to adjust stimulation intensities and support exercises that manage stress urinary incontinence, restore pelvic floor strength, and aid bladder function control. Operations focus on nerve stimulation products for therapeutic applications.
Atlantic Therapeutics's top competitors include Axonics, NeuSpera Medical and Laborie Medical.
Atlantic Therapeutics offers New Collections.
Atlantic Therapeutics has 10 investors. Key investors include SVB, Enterprise Ireland, Andera Partners, Life Sciences Partners, and Western Development Commission.